Net Cash Provided by (Used in) Financing Activities of ORTHOPEDIATRICS CORP from 31 Dec 2015 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
ORTHOPEDIATRICS CORP annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2015 to 31 Dec 2025.
  • ORTHOPEDIATRICS CORP Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $126,000, a 78% increase year-over-year.
  • ORTHOPEDIATRICS CORP annual Net Cash Provided by (Used in) Financing Activities for 2025 was $23,975,000, a 55% decline from 2024.
  • ORTHOPEDIATRICS CORP annual Net Cash Provided by (Used in) Financing Activities for 2024 was $53,135,000, a 628% increase from 2023.
  • ORTHOPEDIATRICS CORP annual Net Cash Provided by (Used in) Financing Activities for 2023 was $7,301,000, a 95% decline from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

ORTHOPEDIATRICS CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $23,975,000 -$29,160,000 -55% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $53,135,000 +$45,834,000 +628% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $7,301,000 -$128,673,000 -95% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2026 2025 FY
2022 $135,974,000 +$135,968,000 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2025 2024 FY
2021 $6,000* -$46,726,000 01 Jan 2021 31 Dec 2021 10-K 08 Mar 2024 2023 FY
2020 $46,732,000 -$44,287,000 -49% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 $91,019,000 +$51,362,000 +130% 01 Jan 2019 31 Dec 2019 10-K 03 Mar 2022 2021 FY
2018 $39,657,000 -$15,077,000 -28% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2021 2020 FY
2017 $54,734,000 +$51,130,000 +1419% 01 Jan 2017 31 Dec 2017 10-K 05 Mar 2020 2019 FY
2016 $3,604,000 +$3,702,000 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019 2018 FY
2015 $98,000 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2018 2017 FY

ORTHOPEDIATRICS CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $126,000 +$447,000 +78% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $573,000 -$537,000 -1492% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $36,000 -$3,000 -9.1% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $33,000 -$63,000 -210% 01 Jan 2022 31 Mar 2022 10-Q 02 May 2023 2023 Q1
Q1 2021 $30,000 +$4,560,000 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $4,530,000 -$5,066,000 -945% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $536,000 +$564,000 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $28,000 -$2,502,000 -101% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $2,474,000 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.